Reported 8 months ago
Sanofi SA has initiated the process of obtaining initial bids for its $20 billion consumer health division while also considering a possible listing of the business. The French pharmaceutical company has requested first-round bids by mid-July, with potential suitors including Advent International, PAI Partners, Blackstone Inc., Clayton Dubilier & Rice, CVC Capital Partners Plc, and TPG Inc. The sale could be one of the largest deals in Europe this year and is part of a trend where pharmaceutical companies split off consumer divisions to focus on developing advanced therapies.
Source: YAHOO